Our experience across hundreds of patients: fewer than 5% stop tirzepatide specifically because of palpitations, and most of those cases involved patients who refused electrolyte repletion or were escalating doses faster than the standard 4-week intervals
Chapela SP, Martinuzzi ALN, Llobera ND, Ceriani F, Gonzalez V, Montalvan M, et al
Mukherjee A, Malik H, Saha AP, Dubey A, Singhal DK, Boateng S, Saugandhika S,Kumar S, De S, Guha SK, Malakar D
6) Consider OTC options with clinician guidance Lifestyle steps are first-line for many people
29 Compared with the phase 3 GLP-1 RA trials that led to FDA approval, a lower percentage of weight reduction was seen in our study
You have more of the curves you want, instead of unwanted curvature